卵巢癌手术治疗中肠切除同期放置腹腔内端口:并发症与手术结局
该研究回顾2005至2016年本机构306例放置腹腔内(IP)端口患者的病历,比较同期行肠切除(IP-BR)与未行肠切除(IP)两组的并发症。结果显示两组IP端口总体并发症率相似,IP化疗完成率无差异,但IP-BR组肠并发症(如梗阻或穿孔)发生率更高(11% vs 2.7%,p=0.01)。
要点
- IP-BR组与IP组IP端口总体并发症率相似(19.2% vs 23.2%,p=0.397)。
- IP-BR组肠并发症(梗阻或穿孔)发生率11% vs IP组2.7%(p=0.01)。
- 最终接受IP化疗者IP-BR组80.2% vs IP组77.8%(p=0.65),无显著差异。
核心结论
- 同期行肠切除放置IP端口的患者似乎未出现更多并发症,也未降低IP化疗给药率。
研究设计与样本
- 回顾性病历审查,纳入2005年至2016年本机构所有放置IP端口的患者,共审查306份病历,分为IP-BR组(同期肠切除)和IP组(未行肠切除)。
主要发现
- IP-BR组占31%;两组平均BMI为25.6 IP-BR vs 27.4 IP(p=0.007)。
- IP-BR组IIIC期患者比例更高(83.3% IP-BR vs 56.9% IP,p≤0.01)。
- 达到R0切除者IP-BR组48.7% vs IP组56.4%(p=0.253)。
- IP化疗前接受IV化疗者IP-BR组90.4%(中位2周期)vs IP组50.3%(中位2周期,p<0.01)。
- 最终接受IP化疗者IP-BR组80.2%(中位4周期)vs IP组77.8%(中位5周期,p=0.65)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine if intraperitoneal (IP) ports placed concurrently with bowel resection during surgical treatment of ovarian cancer is associated with more complications than those ports placed without concurrent bowel resection. METHODS: The medical records of all patients who had an IP port placed at our institution between 2005 and 2016 were reviewed. Two groups were analyzed: IP ports placed with bowel resection (IP-BR) and those without (IP). RESULTS: Of 306 patient charts reviewed, 31% had a surgery with IP port placement and concurrent bowel resection (IP-BR). Demographics were similar except for mean BMI (25.6 IP-BR vs 27.4 IP, p = 0.007). More IP-BR patients had stage IIIC disease (83.3% IP-BR vs 56.9% IP, p ≤0.01). Patients were cytoreduced to R0 in 48.7% IP-BR vs 56.4% IP (p = 0.253). For adjuvant treatment, IV chemotherapy was administered before IP chemotherapy in 90.4% IP-BR (median 2 cycles), and 50.3% IP, (median 2 cycles, p < 0.01). Ultimately 80.2% IP-BR (median 4 cycles) and 77.8% IP (median 5 cycles) received IP chemotherapy (p = 0.65). Rates of total IP port complications were similar (19.2% IP-BR vs 23.2% IP, p = 0.397), including IP port infections (0% IP-BR vs 0.7% IP, p = 0.5). Eleven percent of IP-BR patients had a bowel complication (e.g. obstruction or perforation) while IP port was in situ vs 2.7% IP (p = 0.01). Only 2.7% IP-BR and 6% IP discontinued IP chemotherapy due to IP port complication (p = 0.3). CONCLUSIONS: Patients who have IP ports placed concurrently with a bowel resection do not appear to have more complications, nor lower rates of IP chemotherapy administration.
引用
- Kay AH, Urban RR, Gray HJ, et al. Intraperitoneal ports placed at the time of bowel resection for treatment of ovarian cancer: Complications and surgical outcomes. Gynecol Oncol. 2019. PMID: 31488245. doi:10.1016/j.ygyno.2019.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。